Kidney disease in patients with chronic hepatitis c

Current Gastroenterology Reports

Volumn 3, Issue 1, 2001, Pages 79-83

  Philipneri, Marie ^a   Bastani, Bahar ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cryoglobulinemia; Glomerulonephritis; Membranoproliferative Glomerulonephritis; Membranous Nephropathy; Mixed Cryoglobulinemia

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; RIBAVIRIN;

ANTIGEN ANTIBODY COMPLEX; DISEASE COURSE; GLOMERULONEPHRITIS; HEPATITIS C; HUMAN; IMMUNOLOGY; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; POSTOPERATIVE COMPLICATION; RECURRENT DISEASE; REVIEW; TREATMENT OUTCOME;

ANTIGEN-ANTIBODY COMPLEX; ANTIVIRAL AGENTS; DISEASE PROGRESSION; GLOMERULONEPHRITIS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RIBAVIRIN; TREATMENT OUTCOME;

EID: 0004383642     PISSN: 15228037     EISSN: 1534312X     Source Type: Journal    
DOI: 10.1007/s11894-001-0045-0     Document Type: Article

References (29)

1. Amico G, Colasanti G, Ferrario F, Sinico RA: Renal involvement in essential mixed cryoglobulinemia. Kidney Int 1989, 35:1004–1014.
2. Harle J, Disder P, Dussol B, et al.: Membranoproliferative glomerulonephritis and hepatitis C infection. Lancet 1993, 341:904. DOI: 10.1016/0140-6736(93)93119-L
3. Doutrelepont JM, Adler M, Willens M, Yap SH: Hepatitis C infection and membranoproliferative glomerulonephritis. Lancet 1993, 341:317. DOI: 10.1016/0140-6736(93)92680-R
4. Yamabe H, Johnson RJ, Gretch DR, et al.: Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan. J Am Soc Nephrol 1995, 6:220–223.
5. Johnson RJ, Gretch DR, Yamabe H, et al.: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993, 328:465–470. DOI: 10.1056/NEJM199302183280703
6. Davda R, Peterson J, Weiner R, et al.: Membranous glomerulonephritis in association with hepatitis C virus infection. Am J Kidney Dis 1993, 22:452–455.
7. Stehman-Breen C, Willson R, Alpers C, et al.: Hepatitis C virus associated membranous glomerulonephritis. Curr Opin Nephrol Hypertens 1995, 4:287–294. DOI: 10.1097/00041552-199505000-00015
8. Pol S, Thiers V, Carnot F, et al.: Efficacy and tolerance of alpha-2b interferon therapy on HCV infection of hemodialyzed patients. Kidney Int 1995, 47:1412–1418.
9. Selby P, Kohn J, Raymond J, et al.: Nephrotic syndrome during treatment with interferon. Br Med J 1985, 290:1180.
10. Usalan C, Erdem Y, Altun B, et al.: Rapidly progressive glomerulonephritis associated with hepatitis C virus infection. Clin Nephrol 1998, 49:129–131. A case report of a 20-year-old woman who developed rapidly progressive glomerulonephritis during the course of active HCV infection. Whether this is a true association or a coincidental finding is unknown.
11. Coroneos E, Truong L, Olivero J: Fibrillary glomerulonephritis associated with hepatitis C viral infection. Am J Kidney Dis 1997, 29:132–135.
12. Markowitz GS, Cheng JT, Colvin RB, et al.: Hepatitis C viral infection is associated with fibrillary glomerulonephritis and immunotactoid glomerulopathy. J Am Soc Nephrol 1998, 9:2244–2252. Report of four cases of fibrillary glomerulonephritis and two cases of immunotactoid glomerulopathy in association with HCV infection. Outcomes were variable.
13. Ferri C, Greco F, Longombardo G, et al.: Antibodies against hepatitis C virus in mixed cryoglobulinemia patients. Infection 1991, 19:417–420. DOI: 10.1007/BF01726453
14. Ferri C, Greco F, Longombardo G, et al.: Hepatitis C virus antibodies in mixed cryoglobulinemia. Clin Exper Rheumatol 1991, 9:95–96.
15. Stokes MB, Chawla H, Brody RI, et al.: Immune complex glomerulonephritis in patients coinfected with human immunodeficiency virus and hepatitis C virus. Am J Kidney Dis 1997, 29:514–525.
16. Morales E, Alegre R, Herrero JC, et al.: Hepatitis-C-virusassociated cryoglobulinaemic membranoproliferative glomerulonephritis in patients infected by HIV. Nephrol Dial Transplant 1997, 12:1980–1984. DOI: 10.1093/ndt/12.9.1980
17. Rivera M, Gonzalo A, Maqmpaso, et al.: The heterogeneity of glomerulonephritis associated with HIV. Nephrol Dial Transplant 1999, 14:244–245. Report of four patients with HCV/HIV co-infection who were noted to have the following renal histopathologies: membranous nephropathy in two patients, focal segmental glomerulosclerosis in one, and diffuse proliferative glomerulonephritis in the other. DOI: 10.1093/ndt/14.1.244
18. Beaufils H, Jouanneau C, Katlama C, et al.: HIV-associated IgA nephropathy: a postmortem study. Nephrol Dial Transplant 1995, 10:35–38.
19. Horikoshi S, Okada T, Shirato I, et al.: Diffuse proliferative glomerulonephritis with hepatitis C virus-like particles in paramesangial dense deposits in a patient with chronic hepatitis C virus hepatitis. Nephron 1993, 64:482–484. DOI: 10.1159/000187372
20. Pucillo L, Agnello V: Membranoproliferative glomerulonephritis associated with hepatitis B and C viral infections: from virus-like particles in the cryoprecipitate to viral localization in paramesangial deposits, problematic investigations prone to artifacts. Curr Opin Nephrol Hypertens 1994, 3:465–470. DOI: 10.1097/00041552-199407000-00014
21. Fornasieri A, Armelloni S, Bernasconi P, et al.: High binding of immunoglobulin M kappa rheumatoid factor from type II cryoglobulins to cellular fibronectin: a mechanism for induction of in situ immune complex glomerulonephritis? Am J Kidney Dis 1996, 27:476–483.
22. Sansonno D, Gesualdo L, Manno C, et al.: Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis. Hepatology 1997, 25:1237–1244. DOI: 10.1002/hep.510250529
23. Misiani R, Bellavita P, Fenili D, et al.: Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994, 330:751–756. DOI: 10.1056/NEJM199403173301104
24. Sarac E, Bastacky S, Johnson JP: Response to high-dose alfa interferon after failure of standard therapy in MPGN associated with HCV infection. Am J Kidney Dis 1997, 30:113–115.
25. Johnson RJ, Gretch DR, Couser WG, et al.: Hepatitis C virusassociated glomerulonephritis.: effect of alpha-interferon therapy. Kidney Int 1994, 46:1700–1704.
26. Morosetti M, Sciarra G, Meloni C, et al.: Membranoproliferative glomerulonephritis and hepatitis C: effects of interferon-alpha therapy on clinical outcome and histological pattern. Nephrol Dial Transplant 1996, 11:532–534.
27. Polynard T, Leroy V, Cohard M, et al.: Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology 1996, 24:778–789. DOI: 10.1002/hep.510240405
28. Baid S, Pascual M, Williams W, et al.: Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft receipients. J Am Soc Nephrol 1999, 10:146–153. According to this report, all five patients (out of 18 recipients of HCVpositive serology pretransplant) with biopsy-proven de novo renal thrombotic microangiopathy (RTMA) had a positive ACA test, compared with only one of 13 patients without RTMA. The occurrence of this condition may reflect unfavorable outcome for patient and graft survival.
29. Legendre CH, Garrigue V, Le Bihan C, et al.: Harmful long-term impact of hepatitis C virus infection in kidney transplant receipients. Transplantation 1998, 65:667–670. Report on a retrospective study from France comparing patient survival and cause of death among anti-HCV-positive (n=387) and - negative (n=112) transplant recipients. Anti-HCV-positive patients had significantly shorter patient and graft long-term survival than anti-HCV-negative patients. Increased mortality was primarily due to liver disease and sepsis. DOI: 10.1097/00007890-199803150-00011